F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investors
Hot Fund

IQ Capital

iqcapital.vc · Cambridge, UK

“Frontier technology will underpin the next generation of globally significant companies. We back IP-rich, deep tech founders advancing intelligence, reinventing energy, accelerating computation, decoding biology, and building resilience — categories where traditional venture playbooks don't apply.”

$500K – $40M
Check Size
Leads & Follows
Lead Tendency
$1B
AUM
01Investment Thesis

Frontier technology will underpin the next generation of globally significant companies. We back IP-rich, deep tech founders advancing intelligence, reinventing energy, accelerating computation, decoding biology, and building resilience — categories where traditional venture playbooks don't apply.

Exclusion Criteria

Not a fit for pure consumer/software plays without a genuine deep tech or IP moat; the firm's focus is B2B deep tech across AI, energy, biotech, semiconductors, and security.

02Investment Team
LE
Lucy Edwards
Finance Analyst
LM
Lucy Marston
Finance Analyst
ES
Ed Stacey
Managing Partner
KB
Kerry Baldwin
Managing Partner
MB
Max Bautin
Managing Partner
SH
Simon Hirtzel
General Partner, COO
AM
Archie Muirhead
Partner
AW
Alex Wilson
Partner
JE
Jonno Evans
Partner
MS
Mason Sinclair
Partner
NK
Naoki Kamimaeda
Venture Partner
JB
Jordan Billiald
Principal, Investment Team
KD
Kush Desai
Associate, Investment Team
CC
Céline Caraffa
Research Associate, Investment Team
RS
Ryan Stevens
Head of Portfolio
CM
Conor McCarthy
Head of Finance
EH
Elaine Hegarty
Chief of Staff
CK
Catherine Knott
Executive Assistant / Operations
OF
Oonagh Fawcett Wood
Investor Relations Associate
03F4 Research Brief

IQ Capital Research

Investment Thesis

IQ Capital is a Cambridge, UK-founded deep tech venture capital firm built on the conviction that frontier technology will underpin the next generation of globally significant companies. Founded in 2005 by Ed Stacey, Kerry Baldwin, and Max Bautin, the firm has spent two decades partnering with founders advancing intelligence, reinventing energy, accelerating computation, decoding biology, and building resilience across industrial sectors. IQ Capital explicitly targets IP-rich, breakthrough technologies where traditional venture playbooks don't apply, backing scientists and engineers translating deep research into commercial products across AI & Automation, Advanced Engineering & Energy, Health & Bio, Security & Resilience, Computing & Semiconductors, and Cloud & Enterprise Infrastructure.

Stage Focus

IQ Capital invests from Pre-Seed through Series A as the primary entry point, then reserves substantial follow-on capital through dedicated Growth Opportunity Funds to support winners through internationalization and scale-up rounds (Series B and beyond).

Check Size

Initial checks typically range from roughly $0.5M-$10M+ (reported as low as £0.5M and as high as $10-12.5M depending on hardware intensity), with average seed cheques around $2.5M (up to $5M in hardware-heavy areas). Growth Fund II can deploy up to $40M per company in follow-on capital for outperformers scaling internationally.

Lead Tendency

IQ Capital both leads and follows. It has led rounds outright (e.g., Nuclear Turbines' £15M seed in July 2026, Trogenix's £70M/$95M Series A in October 2025) and participated as a syndicate member in larger rounds led by other institutions (e.g., Nyobolt's Series C led by Symbotic, Nu Quantum's Series A led by National Grid Partners, RevEng.AI's round led by NATO Innovation Fund, IMU Biosciences co-led with Molten Ventures).

Recent Activity

IQ Capital is actively deploying from its $400M pool (Fund IV, $200M venture fund, final close June 2023; Growth Fund II, $200M, launched alongside it), which took total AUM past $1 billion. Notable moves in the last 12 months include:

  • Led a £15M seed round for Nuclear Turbines (July 2026), a BAE Systems nuclear spinout building compact advanced reactor turbines.
  • Backed QuantumDiamonds' €91M round (July 2026) for next-gen chip inspection, continuing from an earlier seed and a €152M Munich manufacturing facility announcement (December 2025).
  • Co-led IMU Biosciences' $53M+ Series A extension (June 2026) for immune-system profiling.
  • Participated in RevEng.AI's $15M Series A (May 2026) for AI-generated software security, alongside NATO Innovation Fund and In-Q-Tel.
  • Backed Nyobolt's $60M Series C at a $1B valuation (May 2026), pushing the ultrafast-charging battery maker to unicorn status.
  • Portfolio company Trogenix published breakthrough pre-clinical glioblastoma data in Nature (April 2026) following its IQ Capital-led £70M/$95M Series A (October 2025).
  • Backed Nu Quantum's record $60M Series A (December 2025), the largest-ever raise for a pure-play quantum networking company.

Portfolio Highlights

IQ Capital has backed over 200 European deep tech founders since 2005 across roughly 60 active companies and 16 acquisitions. Notable active names span quantum (Nu Quantum, QuantumDiamonds), batteries and energy (Nyobolt, Molyon, Nuclear Turbines, IONATE), robotics (Gravis Robotics, Flink, Opteran), semiconductors (Cambridge GaN Devices, Porotech, Signaloid), AI infrastructure and security (Boltzbit, causaLens, Imandra, Mindgard, RevEng.AI, TurinTech), and biotech (DreamFold, Mytos, Trogenix, IMU Biosciences, Baseimmune). Notable exits include Audio Analytic and Bloomsbury AI (both acquired by Meta), Spectral Edge (acquired by Apple), Foundries.io (acquired by Qualcomm), Senseye (acquired by Siemens), Phonetic Arts (acquired by Google), and Neul (acquired by Huawei) — a strong track record of strategic acquirer exits for a deep tech-focused fund.

Team

IQ Capital is led by four General Partners who have worked together for over 20 years, supported by a broader partner and investment team:

  • Ed Stacey — Managing Partner, co-founder
  • Kerry Baldwin — Managing Partner, co-founder
  • Max Bautin — Managing Partner, co-founder
  • Simon Hirtzel — General Partner, COO
  • Archie Muirhead — Partner (promoted from Associate in 2023)
  • Alex Wilson — Partner (promoted from Associate in 2023)
  • Jonno Evans — Partner
  • Mason Sinclair — Partner
  • Naoki Kamimaeda — Venture Partner
  • Jordan Billiald — Principal, Investment Team
  • Kush Desai — Associate, Investment Team
  • Céline Caraffa — Research Associate, Investment Team
  • Ryan Stevens — Head of Portfolio, Operations Team
  • Conor McCarthy — Head of Finance, Operations Team
  • Elaine Hegarty — Chief of Staff, Operations Team
  • Catherine Knott — Executive Assistant / Operations
  • Oonagh Fawcett Wood — Investor Relations Associate
  • Lucy Edwards — Finance Analyst
  • Lucy Marston — Finance Analyst

Decision Process

IQ Capital operates as a multi-GP partnership (four Managing/General Partners plus additional partners), consistent with a partnership-style investment decision process rather than a solo-GP or large investment-committee model.

Founder Preferences

IQ Capital favors deeply technical founding teams — often academic spinouts or engineers/scientists with IP-rich breakthroughs — building in categories where traditional software venture playbooks don't apply: hard science, hardware, and regulated/technical domains requiring genuine defensibility.

Geographic Focus

Primarily UK and European deep tech (Cambridge and London-based, with a strong Cambridge ecosystem bias), with an explicit strategy of building bridges between European and Asian deep tech ecosystems (e.g., the Munich-based QuantumDiamonds facility, Naoki Kamimaeda's Venture Partner role).

04Selected Portfolio
Aerospace & Defense
Alpine Eagle
AgTech & Agriculture
Omegga·Tropic Bio
Biotech & Life Sciences
AiM Medical Robotics·BaseImmune·Closed Loop Medicine·DaltonTx·DreamFold·FocalPoint·Imperagen·Mytos·NanoSyrinx·Neurovalens·Trogenix·Wobble Genomics·Biobeats·Sirigen·IMU Biosciences·Nyobolt
Climate & Sustainability
Molyon·Risilience·Power Challenge·Nuclear Turbines
E-commerce & Marketplaces
Those Beyond
EdTech
Virti
Energy & Power
IONATE·Rivan
Enterprise Software
AccelerComm·Aibuild·Boltzbit·causaLens·Imandra·Myrtle·Signaloid·Speechmatics·Synthesized·ToffeeX·TurinTech·Valarian·V-Sim·Apperio·Audio Analytic·Foundries.io·Neul·Rosslyn·Senseye·Spectral Edge·Spikes Cavell·Nu Quantum
Fintech & Payments
Flink·FNA·MQube·Thought Machine·BMLL
Gaming
Phonetic Arts
Healthcare & Digital Health
Optellum·Pangaea·Pictura Bio·Tagomics
Marketing & Adtech
Grapeshot
Media & Entertainment
Bloomsbury AI
Mobility & Transportation
Charge Point Services
Robotics & Automation
Gravis Robotics·Opteran
Security & Cybersecurity
CyberSmart·CybSafe·Mindgard·OSS·RevEng.AI
Semiconductors & Hardware
Cambridge GaN Devices·Paragraf·Porotech·QuantumDiamonds
Other
Isembard·Quadsat
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (9) →
Led a £15M foundational round for Nuclear Turbines, a BAE Systems spinout building compact advanced nuclear reactor turbines.
INVESTMENT·uktech.news+1
JUL 27, 2026
Participated in QuantumDiamonds' €91M round (equity plus non-dilutive EU Chips Act funding) to scale next-generation semiconductor chip inspection technology.
INVESTMENT·sifted.eu+1
JUL 9, 2026
Co-led (with Molten Ventures) an oversubscribed extension bringing IMU Biosciences' Series A to over $53M for immune-system profiling.
INVESTMENT·businesswire.com
JUN 2, 2026
Participated in RevEng.AI's $15M Series A, led by NATO Innovation Fund, for AI-generated software security verification.
INVESTMENT·iqcapital.vc+1
MAY 27, 2026
Participated in Nyobolt's $60M Series C, led by Symbotic, valuing the ultrafast-charging battery maker at over $1B.
INVESTMENT·businesswire.com
MAY 6, 2026
06Frequent co-investors
EX
East X Ventures
Both backed 3 of the same companies
Rivan, Nu Quantum, ToffeeX
MV
Molten Ventures
Both backed 3 of the same companies
causaLens, IMU Biosciences, Thought Machine
AI
ACF Investors
Both backed 2 of the same companies
BMLL, Neurovalens
AC
Amadeus Capital Partners
Both backed 2 of the same companies
Paragraf, Nu Quantum
DL
Deeptech Labs
Both backed 2 of the same companies
Pictura Bio, Nu Quantum
Find the investors for your round→
Quick Reference
Check Size
$500K – $40M
Stages
Pre-Seed · Seed · Series A
AUM
$1B
Decision
Partnership
Location
Cambridge, UK
Sector Focus
Aerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationClimate & SustainabilityEnterprise SoftwareDeveloper Tools & InfrastructureSecurity & CybersecurityHealthcare & Digital Health
Models
Deep TechB2B
Technology
AI/MLHardwareQuantum ComputingRobotics
See all Aerospace & Defense investors →See all Biotech & Life Sciences investors →See all Semiconductors & Hardware investors →
Visit iqcapital.vc ↗

See how IQ Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Aerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationClimate & SustainabilityEnterprise SoftwareDeveloper Tools & InfrastructureSecurity & CybersecurityHealthcare & Digital Health

See how IQ Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched August 10, 2026F4 Research Engine